Method for treating autoimmune disease
OwnerRalph Rybackinventor
Life of this patent
Estimating the term…
Abstract
The present invention is directed to a method for treating autoimmune diseases comprising administering a therapeutically effective amount of a compound of the following formula (I) 1 wherein X, R1, R2, R3, R4, R5 and R6 are as herein defined.
Claims22
A method for treating an autoimmune disease in a subject in need thereof comprising administering a therapeutically effective amount of a compound of the formula (I):
- 9
- X is CH2 or oxygen;
- R1 is hydrogen or alkyl and
- R2, R3, R4 and R5 are independently hydrogen or lower alkyl and, when X is CH2, R4 and R5 may be alkene groups joined to form a benzene ring and, when X is oxygen, R2 and R3 and/or R4 and R5 together may be a methylenedioxy group of the following formula (II):
- 10
- wherein
- R6 and R7 are the same or different and are hydrogen, lower alkyl or are alkyl and are joined to form a cyclopentyl or cyclohexyl ring.
A method for treating an immune related disease in a subject in need thereof comprising administering a therapeutically effective amount of a compound of the formula (I):
- 11
- X is CH2 or oxygen;
- R1 is hydrogen or alkyl and
- R2, R3, R4 and R5 are independently hydrogen or lower alkyl and, when X is CH2, R4 and R5 may be alkene groups joined to form a benzene ring and, when X is oxygen, R2 and R3 and/or R4 and R5 together may be a methylenedioxy group of the following formula (II):
- 12
- wherein
- R6 and R7 are the same or different and are hydrogen, lower alkyl or are alkyl and are joined to form a cyclopentyl or cyclohexyl ring.
A method for the treatment of psoriasis or multiple sclerosis comprising administering to a subject in need thereof of less than about 50 mg daily of a compound of formula (I)
- 13
- X is CH2 or oxygen;
- R1 is hydrogen or alkyl and
- R2, R3, R4 and R5 are independently hydrogen or lower alkyl and, when X is CH2, R4 and R5 may be alkene groups joined to form a benzene ring and, when X is oxygen, R2 and R3 and/or R4 and R5 together may be a methylenedioxy group of the following formula (II):
- 14
- wherein
- R6 and R7 are the same or different and are hydrogen, lower alkyl or are alkyl and are joined to form a cyclopentyl or cyclohexyl ring.
Dependencies are inferred from the claim text.